Antibody buffering of a ligandin vivo
Authors:
- 22 December 2004
- journal article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 102 (1) , 40-44
Abstract
Clearance is the practical limit on drug action. Here we propose a means of slowing clearance, thereby extending drug lifetime in vivo by "antibody buffering." In this process, a drug and an anti-drug antibody are coadministered. Most of the drug is bound to the antibody, preventing the drug from acting, but also preventing its elimination. A dynamic free drug pool is established by reversible dissociation from the antibody. The free drug is active and can be eliminated, but the free pool is constantly replenished by reequilibration from the antibody-drug complex, giving a long effective lifetime. Here we explore antibody buffering experimentally by using a model compound, 2-phenyloxazol-5-one-gamma-aminobutyrate (Ox), as a drug proxy. We show that antibody buffering can extend by an order of magnitude the plasma lifetime of Ox in rats, and that the steady-state Ox level depends on the molecular properties of the antibody used to buffer the Ox. In addition, the anti-Ox antibody can be recharged with drug in vivo to extend Ox lifetime without additional antibody administration, making this technique even more suitable for possible clinical application.Keywords
This publication has 23 references indexed in Scilit:
- Yeast surface display for screening combinatorial polypeptide librariesNature Biotechnology, 1997
- Isolation of Picomolar Affinity Anti-c-erbB-2 Single-chain Fv by Molecular Evolution of the Complementarity Determining Regions in the Center of the Antibody Binding SiteJournal of Molecular Biology, 1996
- Antibody framework residues affecting the conformation of the hypervariable loopsJournal of Molecular Biology, 1992
- Selecting high-affinity binding proteins by monovalent phage displayBiochemistry, 1991
- Kinetic maturation of an immune responseNature, 1991
- Activation of memory and virgin B cell clones in hyperimmune animalsEuropean Journal of Immunology, 1987
- Somatic mutation and the maturation of immune response to 2-phenyl oxazoloneNature, 1984
- Primate erythrocyte-immune complex-clearing mechanism.Journal of Clinical Investigation, 1983
- Use of Monoclonal Anti-mouse Immunoglobulin to Detect Mouse AntibodiesHybridoma, 1981
- Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific ActivityNature, 1962